快速微生物学检测市场规模、份额及成长分析（按产品、方法、应用、最终用户和地区）－2025-2032 年产业预测

2023 年全球快速微生物检测市场规模为 54.6 亿美元，预计将从 2024 年的 59.4 亿美元成长到 2032 年的 116.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.8%。

随着都市化的加速以及由此造成的水污染，对快速微生物学检测的需求日益增长。水污染可导致多种疾病，包括沙门氏菌感染疾病，每年在美国约有 135 万人感染沙门氏菌。对于可以即时评估的快速生物检测方法的需求日益明显，无需孵化或广泛的化验服务。此外，全球包装食品消费量不断增加，例如最近 Rizo Lopez Foods 因可能受到李斯特菌污染而召回的事件，也凸显了对快速微生物检测方法的需求。这一趋势凸显了对有效的微生物检测解决方案的需求，以增强广泛生产过程的安全性和控制力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

快速微生物学检测市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 装置
• 试剂和套件
• 耗材

快速微生物学检测市场规模（按方法和复合年增长率） (2025-2032)

• 市场概览
• 基于生长的快速微生物学检测
• 基于细胞成分的快速微生物学检测
• 基于核酸的快速微生物检测
• 基于可行性的快速微生物检测

快速微生物学检测市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 临床疾病诊断
• 食品和饮料检验
• 製药和生物技术测试
• 环境测试
• 研究用途

快速微生物学检测市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊断实验室
• 製药和生物技术公司
• 合约研究组织（CRO）
• 学术研究所
• 食品和饮料公司

快速微生物学检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Becton, Dickinson and Company（USA）
• bioMerieux SA（France）
• Danaher Corporation（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Sartorius AG（Germany）
• Bruker Corporation（USA）
• QuidelOrtho Corporation（USA）
• Charles River Laboratories（USA）
• Neogen Corporation（USA）
• Don Whitley Scientific Limited（UK）
• Rapid Micro Biosystems, Inc.（USA）
• Gradientech（Sweden）
• rqmicro AG（Switzerland）
• Colifast AS（Norway）
• Serosep Limited（Ireland）
• Solus PerkinElmer（USA）
• BTNX Inc.（Canada）
• R-Biopharm AG（Germany）

结论和建议

Global Rapid Microbiology Testing Market size was valued at USD 5.46 billion in 2023 and is poised to grow from USD 5.94 billion in 2024 to USD 11.66 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The demand for rapid microbiology testing is escalating in response to growing urbanization and related water pollution, which contributes to various diseases, including those caused by Salmonella, responsible for approximately 1.35 million annual infections in the U.S. Current detection methods are often slow and imprecise, complicating efforts to manage water-borne illnesses. The need for swift biological analysis-capable of real-time assessment without incubation or extensive lab services-is becoming increasingly apparent. Moreover, the global rise in packaged food consumption, highlighted by recent recalls like Rizo Lopez Foods' due to potential listeriosis contamination, reinforces the necessity for prompt microbial testing methods. This trend underscores the critical need for effective microbiology solutions that enhance safety and control within diverse production processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Microbiology Testing Market Segments Analysis

Global Rapid Microbiology Testing Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Instruments, Reagents and Kits and Consumables. Based on Method, the market is segmented into Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing. Based on Application, the market is segmented into Clinical Disease Diagnostics, Food and Beverage Testing, Pharmaceutical and Biotechnology Testing, Environmental Testing and Research Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes and Food and Beverage Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Microbiology Testing Market

The global surge in infectious diseases, particularly hospital-acquired infections (HAIs) and antibiotic resistance, has significantly heightened the demand for rapid microbiological testing. Moreover, escalating investments in healthcare, notably in developing areas, demonstrate a commitment from both governmental bodies and private entities to enhance diagnostic capabilities for effectively managing outbreaks. Additionally, the growing awareness of the importance of early diagnostic accuracy, which positively influences patient outcomes, is further driving the swift adoption of comprehensive microbiological solutions. Consequently, these factors collectively contribute to the robust growth of the global rapid microbiology testing market.

Restraints in the Global Rapid Microbiology Testing Market

Although the global rapid microbiology testing market offers numerous benefits, the high costs associated with advanced testing equipment present a significant barrier for numerous laboratories and healthcare facilities. The financial burden of acquiring sophisticated systems, coupled with ongoing expenses related to infrastructure and maintenance, particularly in low-income and underdeveloped areas, hampers widespread adoption. Additionally, smaller laboratories and hospitals often experience budget limitations, making it challenging to transition from conventional diagnostic methods to rapid microbiological testing solutions. As a result, these financial constraints negatively impact the overall growth potential of the rapid microbiological testing market.

Market Trends of the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market is witnessing a significant trend towards integrating artificial intelligence (AI) and big data analytics, revolutionizing the landscape of microbial diagnostics. This innovation enables AI-driven platforms to process vast quantities of diagnostic data in real time, resulting in quicker and more precise outcomes. Furthermore, such advancements facilitate predictive assessments, which allow healthcare providers to proactively identify potential infection outbreaks and tailor their interventions accordingly. As a result, the demand for sophisticated rapid testing solutions is surging, driving growth in the market and further enhancing the efficiency of microbial detection and management in various sectors, particularly healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Rapid Microbiology Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents and Kits
• Consumables

Global Rapid Microbiology Testing Market Size by Method & CAGR (2025-2032)

• Market Overview
• Growth-Based Rapid Microbiology Testing
• Cellular Component-Based Rapid Microbiology Testing
• Nucleic Acid-Based Rapid Microbiology Testing
• Viability-Based Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Disease Diagnostics
• Food and Beverage Testing
• Pharmaceutical and Biotechnology Testing
• Environmental Testing
• Research Applications

Global Rapid Microbiology Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Food and Beverage Companies

Global Rapid Microbiology Testing Market Size & CAGR (2025-2032)

• North America (Product, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Don Whitley Scientific Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Micro Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gradientech (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• rqmicro AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colifast AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serosep Limited (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solus PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTNX Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations